StockDrifts LogoStockDrifts

Hanju ART 058450

Company
한주에이알티Hanju ART
Insiders
2
Buys
0
Total Value
₩1.6B ($1.1M)
Avg Return
+79.26%
Last Filing
2026-05-07

Hanju ART (058450) has 0 disclosed insider purchases and 5 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩1.6B ($1.1M) in reported transaction value. The earliest filing StockDrifts holds for Hanju ART is dated 2024-03-18; the most recent is 2026-05-07. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +79.26%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-08-06SELLMarket Sell
알에프텍
RF Tech
--1.0K₩3,880+4.4%₩4M ($3K)
2026-08-05SELLMarket Sell
알에프텍
RF Tech
--6.0K₩3,820+2.9%₩23M ($16K)
2026-08-04SELLMarket Sell
알에프텍
RF Tech
--18.8K₩3,980+6.8%₩71M ($49K)
2026-05-07SELLMarket Sell
알에프텍
RF Tech
--28.4K---
2026-05-04SELLMarket Sell
알에프텍
RF Tech
--21.0K---
2026-04-10SELL자본감소
알에프텍
RF Tech
--2.7M₩2,980-40.8%₩7.9B ($5.5M)
2026-01-21BUY유상신주취득
피앤에이투자조합
P&A Investment Association
-4.0M₩1,060-21.2%₩4.2B ($2.9M)
2024-11-05SELL장외매도
알에프텍
RF Tech
--2.1M---
2024-11-05BUY기타
데이뷰네트웍스
Dayview Networks
-2.1M₩2,525-66.9%₩5.3B ($3.7M)
2024-07-09BUY장외매수
알에프텍
RF Tech
-2.0M₩4,120-79.7%₩8.3B ($5.8M)
2024-05-22BUY장외매수
알에프텍
RF Tech
-3.1M₩4,700-82.2%₩14.6B ($10.2M)
2024-05-22SELL장외매도
경남제약
Kyungnam Pharmaceutical
--3.1M₩4,700+82.2%₩14.6B ($10.2M)
2024-05-17SELL장외매도
메타플렉스
metaplex
--1.9M₩4,850+82.8%₩9.0B ($6.3M)
2024-05-07SELLMarket Sell
김병진
Byeongjin Kim
moving-130.4K₩4,240+80.3%₩553M ($384K)
2024-05-03SELLMarket Sell
김병진
Byeongjin Kim
moving-171.4K₩4,010+79.2%₩687M ($477K)
2024-05-02SELLMarket Sell
김병진
Byeongjin Kim
moving-102.5K₩3,845+78.3%₩394M ($274K)
2024-04-15BUY장외매수
알에프텍
RF Tech
-500.0K₩5,270-84.2%₩2.6B ($1.8M)
2024-04-12SELL장외매도
경남제약
Kyungnam Pharmaceutical
--500.0K₩5,400+84.5%₩2.7B ($1.9M)
2024-04-12BUY전환사채의권리행사
김병진
Byeongjin Kim
moving404.2K₩5,400-84.5%₩2.2B ($1.5M)
2024-04-12BUY기타
경남제약
Kyungnam Pharmaceutical
-1₩5,400-84.5%₩5K ($4)
2024-04-12SELL전환등
김병진
Byeongjin Kim
moving-404.2K₩5,400+84.5%₩2.2B ($1.5M)
2024-04-12SELL장외매도
경남제약
Kyungnam Pharmaceutical
--72.8K₩5,400+84.5%₩393M ($273K)
2024-04-12SELL장외매도
경남제약
Kyungnam Pharmaceutical
--91.0K₩5,400+84.5%₩491M ($341K)
2024-04-08SELL행사가액조정
김병진
Byeongjin Kim
moving-112.1K₩3,945+78.8%₩442M ($307K)
2024-03-18SELL행사가액조정
메타플렉스
metaplex
--10.8K₩2,965+71.8%₩32M ($22K)

Frequently asked questions

Who has been buying Hanju ART stock?
2 distinct insiders have filed 0 disclosed insider purchases in Hanju ART (058450), most recently on 2026-05-07. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Hanju ART have?
Hanju ART has 0 buy-side and 5 sell-side disclosures on record, covering ₩1.6B ($1.1M) in total reported value, spanning 2024-03-18 to 2026-05-07.
Where does StockDrifts get Hanju ART insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Hanju ART. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.